期刊文献+

美沙酮维持治疗门诊HIV阳性服药人员吸毒过量死亡的影响因素分析 被引量:3

Factors associated with overdose-caused mortality of HIV-positive patients who were on methadone maintenance treatment program
原文传递
导出
摘要 目的分析影响美沙酮维持治疗(MMT)门诊HIV阳性服药人员吸毒过量死亡的因素。方法采用1:1配对病例对照研究方法,对110例因吸毒过量死亡的服药人员与相应对照(与病例同性别、同门诊、首次入组时间相近)的社会人口学、吸毒行为、服药行为等特征进行比较。结果多因素logistic回归模型分析表明,入组前3个月共用针具(OR=5.19,95%CI:1.39~19.33)、经注射吸毒感染HIV(OR=3.08,95%CI:1.16~8.21)、终点前脱失(OR=2.54,95%C1:1.23—5.23)是吸毒过量死亡的危险因素,而治疗依从性好(OR=O.31,95%CI:0.10。0.95)为保护因素。结论应采取综合措施提高MMT门诊服药病例的依从性,并对曾共用针具的病例展开重点干预,从而减少死亡。 Objective To study the factors that associated with the mortality of overdose on methadone maintenance treatment (MMT) among HIV-positive patients. Methods A 1 : 1 matched case-control design was used to identify the relationship between factors related to demography, drug use, characteristics of treatment and the mortality of overdose. 110 HIV-positive patients who died of drug overdose from March 2004 to September 2012 were defined as cases. Controls were another 110 patients who were still alive and paired with the cases, according to the same gender, similar date of MMT initiation and from the same clinics. Results Multivariate conditional logistic regression analyses indicated that risk factors as sharing needles before enrolled in the MMT program (OR= 5.19, 95% CI: 1.39-19.33) , HIV infection because of injecting drug-use (0R=3.08, 95% Ch 1.16-8.21), and off from the treatment before the end point of the program (0R=2.54, 95%CI: 1.23-5.23 ) were associated with mortality caused by overdose. Higher adherence (OR= 0.31,95%CI.. 0.10-0.95) appeared to be associated with lower mortality when compared with the control group. Conclusion In order to reduce the mortality rate, comprehensive intervention could be introduced to improve the compliance of retention on MMT among patients. Intervention efforts should be focused on those patients who shared needle / syringes.
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2013年第10期961-963,共3页 Chinese Journal of Epidemiology
基金 国家“十二五”科技重大专项(2012ZX10001007-002) 中国艾滋病/结核病多学科研究培训项目(5U2RTW006918)
关键词 美沙酮维持治疗 艾滋病病毒 吸毒 死亡 Methadone maintenance treatment HIV Drug taking Mortality
  • 相关文献

参考文献9

  • 1van Den Broecke SM, De Letter EA, Lambert WE, et al. Methadone-related fatalities:review in the Ghent district between 1978-2008. Acta Clin Belg, 2012,67 (5):352-361.
  • 2Jimenez-Trevino L, Saiz PA, Garcia-Portilla MP, et al. A 25-year follow-up of patients admitted to methadone treatment for the first time: mortality and gender differences. Addict Behav, 2011, 36 (12) : 1184-1190.
  • 3McCowan C, Kidd B, Fahey T. Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study. BMJ, 2009,338: b2225.
  • 4Green TC, McGowan SK, Yokell MA, et al. HIV infection and risk of overdose: a systematic review and meta-analysis. AIDS ,2012,26(4) :403-417.
  • 5刘恩武,王书江,刘燕,刘伟,陈志胜,李秀英,阿丽娅,吴尊友.伊犁哈萨克自治州接受美沙酮维持治疗的HIV感染者死亡情况[J].中华预防医学杂志,2011,45(11):979-984. 被引量:3
  • 6Davoli M, Bargagli AM, Perucci CA, et al. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction, 2007, 102 (12) : 1954-1959.
  • 7Cousins G, Teljeur C, Motterlini N, et al. Risk of drug-related mortality during periods of transition in methadone maintenance treatment: a cohort study. J Subst Abuse Treat, 2011, 41 (3) : 252-260.
  • 8Gu J, Lan JT, Xu H, et al. A randomized controlled trial to evaluate the relative efficacy of the addition of a psycho-social intervention to standard-of-care services in reducing attrition and improving attendance among first-time users of methadone maintenance treatment in China. AIDS Behav,2013,17(6) :2002-2010.
  • 9曹晓斌,吴尊友,庞琳,柔克明,王常合,罗巍,殷文渊,米国栋,李建华.中国首批8个社区美沙酮维持治疗门诊5年治疗效果分析[J].中华流行病学杂志,2012,33(9):879-882. 被引量:23

二级参考文献28

  • 1R Development Core Team. R: a language and environment for statistical computing, reference index version 2. 13.0 [ CP/DK]. Vienna: R Foundation for Statistical Computing, c2011.
  • 2Hooshyar D, Hanson DL, Wolfe M, et al. Trends in perimortal conditions and mortality rates among HIV-infected patients. AIDS, 2007,21:2093-2100.
  • 3Lohse N, Hansen AB, Pedersen G, et al. Survival of persons with and without HW infection in Denmark, 1995 - 2005. Ann Intern Med,2007,146:87-95.
  • 4Blaney T, Craig RJ. Methadone maintenance. Does dose determine differences in outcome? J Subst Abuse Treat, 1999,16:221-228.
  • 5Brady TM, Salvucci S, Sverdlov LS, et al. Methadone dosage and retention: an examination of the 60 mg/day threshold. J Addict Dis, 2005,24 : 23 -47.
  • 6Liu E, Liang T, Shen L, et al. Correlates of methadone client retention: a prospective cohort study in Guizhou province, China. Int J Drug Policy,2009,20:304-308.
  • 7Nosyk B, Marsh DC, Sun H, et al. Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996 - 2006. J Subst Abuse Treat ,2010,39:22-31.
  • 8Serpelloni G, Carrieri MP, Rezza G, et al. Methadone treatment as a determinant of HIV risk reduction among injecting drug users : a nested case-control study. AIDS Care, 1994,6:215-220.
  • 9Gelman A, Hill J. Data Analysis using regression and multilevel/ hierarchical models. Cambridge: Cambridge University Press, 2007.
  • 10Darke S, Zador D. Fatal heroin ' overdose' : a review. Addiction, 1996,91 : 1765-1772.

共引文献23

同被引文献34

  • 1Tian Xin CHU,Judith A LEVY.Injection drug use and HIV/AIDS transmission in China[J].Cell Research,2005,15(11):865-869. 被引量:17
  • 2朱玉,尹潞,阮玉华,郝春,姚辉鸣,杨学贵,边会珍,陈康林,刘莉,冯成玉,秦光明,邵一鸣.四川省西昌市静脉吸毒人群3年随访的死亡情况分析[J].中国自然医学杂志,2006,8(3):170-174. 被引量:11
  • 3庞琳,米国栋,王常合,罗巍,柔克明,李建华,吴尊友,无.我国首批美沙酮维持治疗试点工作效果分析[J].中华实验和临床病毒学杂志,2007,21(1):2-4. 被引量:39
  • 4Yin L, Qin G, Ruan YH, et al. Nonfatal overdose among heroin users in southwestern China [J]. Am J Drug Alcohol Abuse, 2007,33 (4) : 505 -516. DOI: 10.1080/00952990701407223.
  • 5Liu , Bartlett N, Li L, et al. Attitudes and knowledge about naloxone and overdose prevention among detained drug users in Ningbo, China [J]. Substan Abuse Treat Prey Policy, 2012, 7 ( 1 ) : 6. DOI: 10.1 186/1747-597X-7-6.
  • 6Davoli M, Perucci CA, Forateiere F, et al. Risk factors for overdose mortality: a case-control study within a cohort of intravenous drug users [J]. Int J Epidemiol, 1993, 22 (2) : 273 -277. DOI: 10.1093/ij e/22.2.273.
  • 7Darke S, Hall W. Heroinoverdose: research and evidence-based intervention [J]. J Urban Health, 2003,80 (2) : 189-200. DOI: 10.1093/jurbargjtg022.
  • 8Darke S, Zador D. Fatal heroin 'overdose' : a review [J]. Addiction, 1996,91 (12): 1765-1772. DOI: 10.1046/j. 1360-0443. 1996.911217652.x.
  • 9Bartlett N, Xin D, Zhang H, et al. A qualitative evaluation of a peer-implemented overdose response pilot project in Gejiu, China [J]. Int J Drug Policy, 2011, 22 (4) : 301-305. DOh 10.1016/j.drugpo.2011.04.005.
  • 10Tracy M, Piper TM, Ompad D, et al. Circumstances of witnessed drug overdose in New York City: implications for intervention [J]. Drug Alcohol Depend, 2005, 79 (2) : 181-190. DOh 10.1016/j.drugalcdep.2005.01.010.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部